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Available online 6 October 2016White matter disease in the brain increases with age and cardiovascular disease, emerging in midlife, and these
associationsmay be inﬂuenced by both genetic and environmental factors.We examined the frequency, distribu-
tion, and heritability of abnormal white matter and its association with hypertension in 395 middle-aged male
twins (61.9 ± 2.6 years) from the Vietnam Era Twin Study of Aging, 67% of whom were hypertensive. A multi-
channel segmentation approach estimated abnormal regions within the white matter. Using multivariable re-
gressionmodels, we characterized the frequency distribution of abnormalwhitematter inmidlife and investigat-
ed associations with hypertension and Apolipoprotein E-ε4 status and the impact of duration and control of
hypertension. Then, using the classical twin design, we estimated abnormal whitematter heritability and the ex-
tent of shared genetic overlap with blood pressure. Abnormal white matter was predominantly located in
periventricular and deep parietal and frontal regions; associated with age (t= 1.9, p= 0.05) and hypertension
(t= 2.9, p= 0.004), but not Apolipoprotein ε4 status; and was greater in those with uncontrolled hypertension
relative to controlled (t=3.0, p=0.003) and normotensive (t=4.0, p=0.0001) groups, suggesting that abnor-
mal whitemattermay reﬂect currently active cerebrovascular effects. Abnormalwhite matter was highly herita-
ble (a2= 0.81) and shared some genetic inﬂuences with systolic blood pressure (rA= 0.26), although there was
evidence for distinct genetic contributions and unique environmental inﬂuences. Future longitudinal research
will shed light on factors impacting white matter disease presentation, progression, and potential recovery.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Heritability1. Introduction
The incidence and prevalence of white matter disease increase with
age, and white matter damage has been associated with cerebro- and
cardiovascular disease, as well as cognitive impairment and even
Alzheimer's disease (Bigler et al., 2002; Gunning-Dixon et al., 2009;
Gunning-Dixon and Raz, 2000; Valdes Hernandez et al., 2014). Underly-
ing causes of white matter disease include vasculopathy, de-
myelination, and gliosis, although the most common cause associatedapolipoprotein E; SBP, systolic
ypertension; BMI, body mass
RP, C-Reactive protein; ICV,
8, University of California, San
stine).
. This is an open access article underwith aging and cerebrovascular disease is ischemic pathogenesis, or
small cerebral vessel disease (Fazekas et al., 1993; Gunning-Dixon et
al., 2009; Kim et al., 2008). Magnetic resonance imaging (MRI) can de-
tect such damage, providing measures of abnormal white matter
(AWM) including white matter hyperintensities of presumed vascular
origin, lacunes, and small subcortical infarcts (all hyperintense areas
on T2-weighted or FLAIR and iso- or hypo-intense regions on T1)
(Wardlaw et al., 2013). By age 90, an individual may have more than
six times as much AWM as at age 30 (Jernigan et al., 2001). Little is
known, however, about the extent and distribution of AWMspeciﬁcally
within middle-age (~50–65 years). Rather, most studies include indi-
viduals over the age of 70 or a broad age range (anywhere from late ad-
olescence to 85 years) without large representation of middle-aged
individuals. A rating-based study of individuals aged 16–65 reported
that those 55 to 65 years of age (n=31) had a 10-fold increase in prev-
alence of AWM compared to those 16–54, although AWM wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ically on midlife, when such abnormalities begin to substantially in-
crease, are necessary to more fully understand factors inﬂuencing
white matter disease.
Hypertension, a strong risk factor for cerebrovascular disease, has
been associated with white matter disease (de Leeuw et al., 2002;
Knopman et al., 2011; Liao et al., 1997; Raz et al., 2012; Valdes
Hernandez et al., 2014), and shares a similar increase in incidence be-
ginning inmidlife (Qiu et al., 2005). Elevatedmidlife systolic blood pres-
sure (SBP) has been linked to late life structural brain changes and poor
cognitive functioning (Swan et al., 1998), whichmay be particularly se-
vere with uncontrolled hypertension (van Dijk et al., 2004). Hyperten-
sion may exacerbate effects of normal aging on the brain
(Strassburger et al., 1997), and the study of middle-aged individuals
may provide an early window into the association between emerging
hypertension and white matter disease.
Understanding the genetic and environmental contributions to
white matter disease and the basis of its association with hypertension
may be important to better guide prevention and intervention strate-
gies. An early report in older men from the National Heart, Lung, and
Blood Institute (NHLBI) Twin study (n = 290; mean age = 72, sd =
2.8) supports a strong genetic contribution (h2 = 0.71) to AWM
(Carmelli et al., 1998), and the San Antonio Family Heart Study of
healthy Mexican Americans (n = 459; aged 19–85), using a family-
based approach, estimated similar heritability (0.72) (Kochunov et al.,
2009). Another family/pedigree-based study of both men and women
across a broad age range (n = 1330; mean age = 61 years, range 34–
88) from the Framingham Heart Study, however, reported somewhat
lower heritability (0.55) (Atwood et al., 2004), and heritability tended
to increasewith age inmales (from0.52 to 0.66). In the Older Australian
Twin Study (Sachdev et al., 2013), AWMwas highly heritable (0.79) in
individuals older than 64 years (n=404;mean age=70.8). As individ-
uals age, the relative prominence of genetic versus environmental inﬂu-
encesmay change. For example, in our evaluation of ventricular volume,
the variance of which increaseswith age as does AWM,we found great-
er genetic inﬂuences later in life (Kremen et al., 2012). Thus, the herita-
bility of AWM amongmiddle-aged adults may differ from the estimates
reported in prior studies.
Blood pressure has also been shown to be heritable across a variety
of cohorts; estimates range from 0.34 to 0.60 for SBP and 0.34 to 0.67
for diastolic blood pressure (DBP) (1978; Hottenga et al., 2005; van
Rijn et al., 2007). There is evidence for shared genetic inﬂuences be-
tween BP and white matter integrity assessed by diffusion tensor imag-
ing (Kochunov et al., 2011) and AWM volumes (Kochunov et al., 2010)
in family/pedigree based studies of broad age range samples (19–79 and
19–85 respectively). These and other studies support the potential in-
ﬂuence of complex age-related factors modifying genetic associations
and impacting measured white matter disease (Atwood et al., 2004;
Kochunov et al., 2010; Kochunov et al., 2011). The present study ex-
tends prior work to examine the genetic overlap between BP and
AWM within a restricted midlife age range to reduce the inﬂuence of
potentially complex age-related factors.
Studies of speciﬁc genes also may provide insight into the causes of
whitematter disease. The Apolipoprotein E (ApoE) ε4 allele is of interest
due to a relationship with greater risk for cerebrovascular disease, exac-
erbation of white matter disease in the presence of vascular diseases,
and association with increased risk for Alzheimer's disease (DeCarli et
al., 1999). Although there is evidence of an association between the ε4
allele and AWM in the context of older age and Alzheimer's disease
(Brickman et al., 2014), it is not clear whether ε4 carrier status would
have such a direct association in midlife, as there is evidence for com-
plex underlying interactions among factors (Kalmijn et al., 1996).
The purpose of the present study is to deﬁne the distribution and
heritability of AWM and its phenotypic and genetic associations with
hypertension in a community-based sample of middle-aged (aged 56–
66 years) male twins from the Vietnam Era Twin Study of Aging(VETSA; Kremen et al., 2013; Kremen et al., 2006). We proposed that
AWM would be related to hypertension and that the ApoE-ε4 allele
would be associated with more AWMonly in the presence of hyperten-
sion.Wehypothesized that AWMwould bemore common andworse in
individuals with longer duration of hypertension andwith uncontrolled
hypertension. Finally, using the classical twin design, we estimated the
heritability of AWMand the extent of shared genetic and environmental
inﬂuences between AWM and blood pressure. Findings from this mid-
life cohort exhibiting emerging white matter disease and hypertension
are discussed in the context of existing studies that explore broad age
ranges and older cohorts.
2. Materials and methods
2.1. Participants
Participants in the parent VETSA cohort were recruited from the
Vietnam Era Twin Registry, a nationally distributed sample of male-
male twin pairs who served in the United States military at some
point between 1965 and 1975 (Goldberg et al., 2002), and were in
their 50s at initial recruitment (Kremen et al., 2006). The VETSA MRI
study is a subset described previously (Kremen et al., 2013; Kremen et
al., 2010); during Wave 2, MRI data included protocols for quantitative
estimation of white matter disease which are used herein. Participants
were similar in health and lifestyle characteristics to American men in
their age range (Schoenborn and Heyman, 2009), and most (~80%)
did not experience combat. Participants traveled either to San Diego
or Boston for the study. Informed consent was obtained from all partic-
ipants, the protocol was approved by Institutional Review Boards at the
University of California, San Diego (UCSD), Boston University, and the
Massachusetts General Hospital (MGH), and all procedures were in ac-
cordance with institutional guidelines. The available sample included
395 individuals: 86 monozygotic (MZ) twin pairs (n = 172); 63 dizy-
gotic (DZ) twin pairs (n = 126); 97 unpaired twins. The average age
was 61.9 years (SD = 2.6; range 56–66), most were non-Hispanic
white (88%; African American 7%).
2.2. Hypertensive status
SBP and DBP were measured as the average of 2 A.M. and 2 P.M.
seated readings with an electronic sphygmomanometer (Omron
Model HEM-757/Wave 1; LifesourceModel UA-789 AC/Wave 2). Partic-
ipants rested for 5 min prior to the ﬁrst reading in each set, wearing a
blood pressure cuff on their dominant arm with their arm resting on a
table. Participants rested quietly for 1min between the paired readings.
Hypertension was determined on the basis of SBP ≥ 140 mmHg, DBP ≥
90 mm Hg, or self-report of a physician diagnosis. For hypertension
analyses, we conservatively excluded individuals (n = 22) who were
using hypertensive medication without evidence of use speciﬁcally for
hypertension, thus, the cross-sectional association of hypertension and
AWM was based on 373 individuals.
A subset of these individuals (n= 297) had additional longitudinal
data on hypertensive status at Wave 1 approximately 5.5 (SD = 0.5)
years earlier. To examine the association of duration of hypertension
with AWM, we categorized participants with hypertension at both
waves as longer duration and those who met criteria only at Wave 2
as more recent onset. We also categorized participants on the basis of
whether their hypertension was controlled (SBP b 140 mm Hg and
DBP b 90) or uncontrolled.
2.3. ApoE genotype
ApoE genotype was determined from blood samples using
established methods (Emi et al., 1988; Hixson and Vernier, 1990).
ApoE-ε4 allele status was available for 385 of the 395 participants, and
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one ε4 allele.
2.4. Health and lifestyle covariates
Height and weight were measured, and body mass index (BMI) cal-
culated. Diabetes status was ascertained from self-report of a doctor's
diagnosis or reported use of a diabetes-related medication. Fasting
blood samples were obtained for low- and high-density lipoprotein
(LDL and HDL), cholesterol, and triglycerides via spectrophotometry,
and for C-Reactive protein (CRP) via nephelometry. CRP values of 10
or higher were assumed to reﬂect acute infection, and these cases
(n = 12) were excluded. Samples available included 369 for LDL, 374
for HDL, and 372 for CRP. Assays were conducted by Quest Diagnostics
Inc./Nichols Institute, San Juan Capistrano, CA.
2.5. Multi-channel structural MRI protocol and image analysis
T1-, T2-, and proton-density- (PD) weighted images were acquired
at UCSD and MGH. UCSD used a GE 3 T Discovery 750 scanner with an
8-channel phased array head coil: sagittal 3D fast spoiled gradient
echo (FSPGR) T1 with TE = min/full, TI = 600ms, ﬂip angle = 8°,
FOV = 25.6 cm, frequency = 256, phase = 192, slices = 172, slice
thickness = 1.2 mm; a coronal 2D FRFSE-XL T2 with 2 mm slice thick-
ness, FOV = 24 cm, TE = 94 ms, TR = 4.6 s, ETL = 16, frequency =
256, phase = 256, 2 NEX; and a coronal 2D FSE-XL PD with 2 mm
slice thickness, FOV=24 cm, TE=min/full, TR=3 s, ETL=4, frequen-
cy = 256, phase = 256. MGH used a Siemens 3 T Tim Trio with a 12-
channel head coil: sagittal 3D magnetization-prepared rapid gradient-
echo (MPRAGE) T1 with TE = 4.3, TR = 2170 ms, TI = 1100ms, ﬂip
angle = 7°, slices = 160, slice thickness = 1.2mm; a coronal 2D TSE
T2 with 2 mm slice thickness, FOV = 24 cm, TE = 93 ms, TR = 4.7 s,
ETL = 24, 2 NEX; and a coronal 2D TSE PD with 2 mm slice thickness,
FOV = 24 cm, TE = 19 ms, TR = 3 s, ETL = 12.
We used a multi-channel segmentation approach to measure AWM
in addition to total cerebral white matter, total gray matter, total cere-
brospinal ﬂuid (CSF), and intracranial vault volumes (based on
Fennema-Notestine et al., 2013; Jernigan et al., 2011) (Fig. 1). This ap-
proach leverages complementary information in three volumes to in-
crease measurement sensitivity while reducing the impact of MR
acquisition noise. Steps include standard alignment of the T1 (i.e., 6 de-
grees-of-freedom, rigid transformation to an anterior/posterior com-
missure aligned space), registration of T2 and PD to T1 using a mutual
information method (based on Maes et al., 1997), bias-correction
usingN3 (Sled et al., 1998), and a three-class tissue segmentation utiliz-
ing Scott's L2Emethod (Scott, 2001) to determine robustmeans and co-
variances for white matter, gray matter, and CSF. AWM was classiﬁed
using morphological operators (Yoo et al., 2002) to identify voxel clus-
ters originally segmented as gray matter that fell within anatomically
deﬁned white matter regions; results were visually reviewed and man-
ually edited when necessary to correct misclassiﬁcations. All tissue vol-
umes were measured in each subject's (undeformed) space. Since
partial voluming of ﬂuid and white matter along the edges of ventricles
results in voxels with AWM-like signal, even in healthy individuals, we
did not allow any voxels that touched (i.e., shared a common face, edge,
or vertex with) a ventricular ﬂuid voxel to be classiﬁed as AWM; such
voxels were excluded from the estimated volumes. Following AWM
classiﬁcation, we constructed an AWM frequency atlas to present the
anatomical distribution. Each T1 was nonlinearly warped to the MNI-
152 atlas (Fonov et al., 2011) using Advanced Normalization Tools
(Avants et al., 2011). Then, each subject's four-class (gray, white, CSF,
abnormal white) tissue segmentation was warped to MNI-152 space,
using nearest neighbor interpolation and the subject speciﬁc nonlinear
warps calculated for each T1. The value of each voxel in the frequency
atlas represents the proportion of subjects across the sample that have
AWM at that voxel's location in MNI-152 space.2.6. Statistical analysis
Volumetric measures were log-transformed to symmetrize the dis-
tributions and stabilize the variances; due to non-normal distributions,
LDL, HDL, and CRP also were log-transformed.2.6.1. Non-twin analyses
We employed linear mixed effects models with ﬁxed effects of scan-
ner (Barnes et al., 2010; Fennema-Notestine et al., 2007) and age. To ad-
just for the non-independence of twins within pairs, the “family ID” of
each twin pair was entered as a random effect. When using volumes,
the log of the total intracranial vault (ICV) volume was included as a
ﬁxed effect to adjust for individual differences in head size. Statistical ef-
fects are reported for t and p values associatedwith parameter estimates
from the models, with an alpha level of 0.05.
AWMwas examined both as a proportion of total white matter (i.e.,
howmuchof thewhitematterwas abnormal) and as a total volume; re-
ported values are for the proportion of AWM unless otherwise noted.
We estimated the association between AWM and hypertension status
at Wave 2 (n= 373). In a second model, we added ε4 status and a hy-
pertension HTN × ε4 status interaction; 9 cases were excluded because
ApoE information was not available. Finally, we explored the impact of
duration of hypertension (normotensive, longer, or more recent) and
the effectiveness of controlling hypertension (controlled, uncontrolled)
on AWM using the subset of available Wave 1 individuals (n= 297).2.6.2. Twin analyses
We ﬁt univariate biometrical (ACE) models to AWM and total white
matter; measures were adjusted for age, scanner and, for volumes only,
ICV. In the twin design the variance of a phenotype is decomposed into
the proportion attributed to additive genetic (A), common environmen-
tal (C), and unique environmental (E) inﬂuences (Eaves et al., 1978;
Neale and Cardon, 1992). Additive genetic inﬂuences are assumed to
correlate 1.0 between MZ twins and 0.50 for DZ twins. Shared environ-
ment is assumed to correlate 1.0, and unique environmental inﬂuences
are uncorrelated between themembers of a twin pair. The proportion of
variance attributable to additive genetic inﬂuences is the heritability.
To examine the interplay of AWM, SBP, and DBP, we performed a
trivariate ACEmodel. This estimates genetic and environmental correla-
tions between variables, or the degree of shared genetic and environ-
mental variance. Continuous BP measures, rather than categorical
hypertension status,were used to increase our power for detecting a ge-
netic covariance. We used medication-corrected (Rana et al., 2014) BP
estimates because medication may mask associations of hypertension
with genetic status. These were calculated by leveraging data from the
larger VETSA sample (n = 1237) (Rana et al., 2014). Twin analyses
were performed using the maximum-likelihood based structural
equation modeling software OpenMx (Boker et al., 2011; Neale et al.,
2016).3. Results
3.1. Frequency and distribution of AWM in midlife
The distribution of AWM across the entire sample was broad and
skewed ranging from 0.1% to 16.6% of the white matter being abnormal
(median=0.9%, IQR= [0.5–1.8]). The percent of ICV volume accounted
for by AWM ranged from 0.03% to 5.1% (median = 0.3%, IQR = [0.1–
0.6]). Statistical analyses used the log-transformed variables for propor-
tion of white matter that was abnormal to address the skewness of the
data. AWM was broadly distributed, but most commonly located in
periventricular regions and the deep white matter of the parietal and
frontal lobes (Fig. 2).
Fig. 1. Abnormal white matter. Three example coronal sections, in locations similar to Fig. 2, from one case reﬂecting approximately the 75th percentile (0.79) of proportion of AWM. Top
row: anatomical segmentation; Middle row: T2-weighted images; and Bottom row: T1-weighted images. Sections are taken from posterior (left) to anterior (right). RED = abnormal
white matter; BLUE = CSF; LIGHT GRAY = white matter; DARK GRAY= gray matter.
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Of the 373 participants, 250 (67%) were hypertensive at Wave 2
(Table 1). Individuals with hypertension had a larger proportion of
AWM (t = 2.9, p = 0.004; Fig. 3A) and a greater volume of AWM
(t= 3.0, p= 0.003). The proportion of AWM for hypertensive individ-
uals ranged from0.1% to 16.6% (median=1.0%, IQR= [0.5%–1.9%]), rel-
ative to normotensives who ranged from 0.1% to 5.1% (median = 0.7%,
IQR = [0.4%–1.7%]). For additional reference, the distribution of log-
transformed raw (uncorrected) AWM volumes by group is presented
in Supplementary Fig. S1. Individuals with hypertension had smallergraymatter volumes (t=−3.3, p=0.001), but total white matter vol-
ume was not different by hypertension status (t b 1.0), and CSF volume
only tended to be different (t=1.9, p=0.06). Evenwithin this restrict-
ed age range (56–66), older age also was subtly associated with more
AWM in the full model (t = 1.9, p = 0.05; Spearman's ρ = 0.08),
with less gray matter (t =−3.8, p = 0.0002) and more CSF (t = 4.6,
p = 0.0001). Age only tended to be related to total white matter
(t=−1.9, p= 0.06). There was no effect of or interaction with ApoE-
ε4 status for any measures (all t ≤ 1; for ApoE group characteristics,
see Supplementary Table S1). Hypertensive and normotensive groups
did not differ on age, ApoE-ε4 allele status, or HDL levels; however,
Fig. 2. Abnormal white matter frequency atlas. The spatial distribution and most common areas of AWM are shown overlaid on an averaged T1. High to low frequency ranged from 0.76
(red) to 0.01 (dark blue) of the sample with AWM in a given voxel. Top row: three coronal sections from posterior to anterior (left to right). Bottom row includes one axial (left) and one
sagittal (right) view. Voxels displayed were designated as AWMwith minimum threshold of 0.01 (n = 4).
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levels, as well as lower LDL and a higher prevalence of diabetes
(Table 1).
3.3. Duration and control of hypertension
Of the 204 hypertensive individuals with data available in Wave 1,
81% had longer duration hypertension and 19% had more recent onset
hypertension (Table 2). The longer duration group had more AWM rel-
ative to the normotensive group (t=2.6, p=0.01; Fig. 3B). Therewas a
trend for the recent group to have more AWM than the normotensive
group (t = 1.8, p = 0.07), although the recent and longer duration
groups did not differ (t b 1.0, p = 0.97) (Fig. 3B). The longer duration
and recent onset groups did not differ signiﬁcantly on HDL, ApoE-ε4 sta-
tus, or age, although the longer duration group tended to be older thanTable 1
Demographic and health characteristics of Wave 2 hypertensive sample.
Wave 2 hypertension
Group difference
tNo
(n = 123)
Yes
(n = 250)
Age, yrs 62.0 (2.6) 61.7 (2.6) 0.9ns
BMI 26.9 (3.9) 29.3 (4.0) −5.5***
SBP 120.1 (9.3) 132.1 (16.8) −7.4***
DBP 74.7 (6.2) 80.4 (9.6) −6.0***
HDL 51 (15) 49 (14) 1.6 ns
LDL 120 (37) 102 (31) 4.4***
CRP 1.6 (1.7) 2.3 (2.2) −4.2***
HTN meds – 69%
Diabetes 6% (7) 18% (45) X2 = 12***
ApoE-ε4 25% (31) 22% (55) X2 = 0.9ns
Values are mean and (SD) unless otherwise speciﬁed. yrs = years; BMI = body mass
index; HDL= high density lipoprotein; LDL= low density lipoprotein; CRP = C-reactive
protein; HTN Meds = antihypertensive medication; ApoE = apolipoprotein E. t value:
ns = not signiﬁcant; *p b 0.05; **p b 0.01; ***p b 0.001.the recent group (t = 2.3, p = 0.06) (Table 2). The longer duration
group had higher BMI relative to normotensives, and both hypertension
groups had lower LDL and higher CRP levels as well as a higher preva-
lence of diabetes, but were not different from each other on these mea-
sures. Hypertension groups did not differ on anti-hypertensive
medications, controlled hypertension, or diabetes.
Of these same 204 individuals, 68% had controlled hypertension and
32% had uncontrolled hypertension at Wave 2 (Table 3). The uncon-
trolled hypertension group had more AWM than the controlled (t =
3.0, p = 0.003) and normotensive groups (t = 4.0, p = 0.0001); the
controlled group did not differ from the normotensive group (t= 1.6,
p = 0.11; Fig. 3C). The uncontrolled group had higher BMI relative to
the controlled andnormotensive groups,while thehypertension groups
did not differ on age, HDL, LDL, CRP, or ApoE-ε4 status (Table 3). The
controlled group had more individuals on hypertension medications
andmorewith diabetes, but did not differ from uncontrolled on propor-
tion of longer duration hypertension. Relative to the normotensive
group, the controlled group had higher BMI, SBP, and CRP as well as a
higher incidence of diabetes.
3.4. Heritability of abnormal white matter
AWM showed strong genetic inﬂuences (heritability = 0.81) (a2 in
Table 4); unique environmental inﬂuences (e2) accounted for approxi-
mately 19% of the variance. Common environmental inﬂuences (c2)
did not signiﬁcantly contribute to the model.
3.5. Genetic associations between AWM and BP
In the full trivariate model, the heritability of SBP was 0.44 and that
of DBPwas 0.46 (Table 5); AWMheritabilitywas similar to that found in
the univariate model (a2 = 0.80). Unique environmental inﬂuences
accounted for the remaining variances. Signiﬁcant phenotypic correla-
tions (rP) with AWM were demonstrated for both SBP (0.18) and DBP
Fig. 3.Abnormalwhitematter by A) hypertension status, B) duration of hypertension, and
C) control of hypertension. Values reﬂect estimated marginal means and standard error
bars from the full models using the log transformed data to control for the inﬂuence of
scanner, age, and the non-independence of the twin sample.
Table 3
Demographic and health characteristics of hypertension control groups.
Normotensive
(n = 93)
Controlled
(n = 138)
Uncontrolled
(n = 66)
Group differences
Age, yrs 61.9 (2.6) 62.0 (2.5) 61.3 (2.6) –
BMI 26.8 (4.0) 28.6 (4.1) 30.1 (3.9) N b C⁎⁎ b U⁎
SBP 118.8 (8.9) 122.8 (10.2) 150.7 (12.4) N b C⁎ b U⁎⁎⁎
DBP 74.1 (6.5) 75.9 (7.1) 89.4 (7.8) N = C b U⁎⁎⁎
HDL 52 (14) 49 (15) 49 (13) –
LDL 120 (40) 99 (32) 110 (31) N N C⁎⁎ = U
CRP 1.5 (1.7) 2.3 (2.4) 2.4 (2.2) N b C⁎⁎ = U
HTN meds – 80% 47% C N U⁎⁎⁎
Diabetes 5% 24% 10% C N U⁎,N⁎⁎⁎
ApoE-ε4 27% 25% 20% –
Values are mean and (SD) unless otherwise speciﬁed. yrs = years; BMI = body mass
index; HDL= high density lipoprotein; LDL = low density lipoprotein; CRP = C-reactive
protein; HTN Meds = antihypertensive medication; ApoE = apolipoprotein E. t value:
⁎p b 0.05; ⁎⁎p b 0.01; ⁎⁎⁎p b 0.001.
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genetic inﬂuences for SBP (86.7%) andDBP (72.7%). A signiﬁcant genetic
correlation was observed between AWM and SBP (rA = 0.26), but not
for DBP.Table 2
Demographic and health characteristics of hypertension duration groups.
Normotensive
(n = 93)
Recent
(n = 38)
Age, yrs 61.9 (2.6) 60.1 (2.7)
BMI 26.8 (4.0) 28.2 (4.7)
SBP 118.8 (8.9) 130.1 (15.3)
DBP 74.1 (6.5) 79.5 (10.2)
HDL 52 (14) 45 (9)
LDL 120 (40) 99 (31)
CRP 1.5 (1.7) 2.9 (2.8)
HTN meds – 60%
Diabetes 5% 26%
ApoE-ε4 27% 29%
Values are mean and (SD) unless otherwise speciﬁed. yrs = years; BMI = body mass index; H
HTN Meds = antihypertensive medication; ApoE= apolipoprotein E. t value: *p b 0.05; **p b 04. Discussion
The present study provides a phenotypic and genetic characteriza-
tion of white matter disease in a community-based middle-aged cohort
of men. The presence of abnormalities was clear, most commonly in the
periventricular regions and the deep white matter of the parietal and
frontal lobes. Even within this narrow midlife age range (56–66
years), the amount of AWM increased with age. AWM was related to
hypertension and more evident in individuals who had uncontrolled
hypertension. There was no apparent effect of ApoE-ε4 status. AWM
was highly heritable in this midlife sample and genetic overlap was
demonstrated between AWM and SBP but not DBP. There also were in-
dependent unique genetic and environmental inﬂuences on AWM.
The extent and distribution of AWM in this large midlife male sam-
ple appears to fall on the cusp of normal age-related increases and in a
pattern similar to studies of older adults. Direct comparisons of the
amount of AWM to existing literature are challenging due to varied
methods [e.g., ratings (Hopkins et al., 2006); segmentation (Jernigan
et al., 2001); MRI sequences (Raz et al., 2012)], and statistical reports
of different metrics, often averaging across broad age ranges. With
these challenges in mind, our overall AWM raw volume (mean =
6843mm3;median=3803mm3) falls above a reportedmean averaged
across the age range of 34–88 years (mean age = 60.7; mean = 940
mm3) in a study using a relatively similar T2/PD segmentation approach
(n= 626 men) (Atwood et al., 2004), as would be expected given the
inclusion of many younger individuals who likely have no measurable
AWM. Our AWM volumewas slightly above a reported mean in 144 in-
dividuals ages 44–77 years (mean age = 58.9; 46 men; mean = 5533
mm3), although this study relied on manual tracing of FLAIR images
(Raz et al., 2012). Finally, our AWM volume as a percentage of ICV
(mean = 0.47%, range 0.03%–5.1%) can be cautiously interpreted as
falling within linear estimates proportionalized to the smallerLonger
(n = 166)
Group differences
62.0 (2.5) –
29.3 (3.9) Longer N Norm⁎⁎⁎
132.2 (17.4) Longer and Recent N Norm⁎⁎⁎
80.5 (9.6) Longer and Recent N Norm⁎⁎
50 (15) –
103 (33) Norm N Longer and Recent⁎⁎
2.2 (2.1) Longer and Recent N Norm⁎⁎
72% –
17% Longer and Recent N Norm⁎⁎
22%⁎ –
DL = high density lipoprotein; LDL = low density lipoprotein; CRP = C-reactive protein;
.01; ***p b 0.001.
Table 4
Univariate twin model ﬁtting results for white matter measures.
Model ﬁt Standardized variance components
Phenotype rMZ rDZ −2LL LRT p a2 (95% CI) c2 (95% CI) e2 (95% CI)
Proportion of AWMa 0.85 0.34 1004.31 5.67 0.4609 0.81 (0.61; 0.86) 0.00 (0.00; 0.19) 0.19 (0.14; 0.26)
AWMa,b 0.85 0.34 1003.26 5.88 0.4362 0.81 (0.61; 0.87) 0.00 (0.00; 0.19) 0.19 (0.13; 0.26)
Total white mattera,b 0.83 0.40 1004.33 3.54 0.7387 0.85 (0.62; 0.89) 0.00 (0.00; 0.22) 0.15 (0.11; 0.22)
rMZ=monozygotic and rDZ=dizygotic twin correlations.−2LL=Negative 2 log-likelihood; LRT=Likelihood ratio test; a2=Additive genetic, c2=Common/Shared environmental, and
e2 = Unique environmental inﬂuences; CI = conﬁdence intervals. aAdjusted for scanner and age; bAlso adjusted for ICV.
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estimates) for ages 30 (0.50%) and 90 (3.0%) (Jernigan et al., 2001).
The distribution of AWMwas similar to that reported for older age in
general, emphasizing periventricular regions and deep frontal and pari-
etal white matter locations (Fig. 2) (de Leeuw et al., 2001; de Leeuw et
al., 2002; Jernigan et al., 2001; 7 et al., 2014; Zhu et al., 2012).
Periventricular white matter hyperintensities are common, as these
are watershed zones of circulation (Awad et al., 1986b; Fazekas et al.,
1993), and may be primarily vascular in nature (Awad et al., 1987;
Fazekas et al., 1993; Wardlaw et al., 2013), although gliosis and myelin
degeneration may be present (Awad et al., 1986a; Awad et al., 1987).
Periventricular caps in particular have been shown to be of non-ische-
mic origin, associated with myelin pallor and dilated perivascular
spaces, whereas punctate abnormalities can reﬂect ischemic tissue
damage (Fazekas et al., 1993; Wardlaw et al., 2013). Deep white matter
abnormalities included hyperintensities of presumed vascular origin,
small subcortical infarcts and lacunes, some of which are thought to
be associated with ischemic tissue damage ranging from mild
perivascular alterations to large areas of ﬁber loss and arteriosclerosis
(Kim et al., 2008; Wardlaw et al., 2013).
Hypertension was associated with more AWM even controlling for
age. Poorly-controlled hypertension was clearly associated with more
white matter damage, whereas well-controlled hypertension was asso-
ciated with less apparent current damage. In contrast, our work using
diffusion tensor imaging showed little effect of controlled hypertension
on alterations of white matter microstructure (McEvoy et al., 2015).
This might suggest that macrostructural AWM is more strongly associ-
ated with currently active cerebrovascular effects. Future longitudinal
analyses will allow insight into whether some controlled hypertensives
can return to more normal levels of brain integrity if hypertension is
treated sufﬁciently early in the disease.
Although the proportion of AWM in the recent and longer duration
hypertension groups was nearly identical, only the longer duration
group had signiﬁcantly more AWM relative to the normotensive
group. Given the small sample size of the recent group (n = 38), the
most parsimonious explanation may be that there was an effect of the
presence, but not duration, of hypertension in this sample. Our diffusion
study and previous work indicate similar ﬁndings, with no effect of du-
rationwithin this time frame (McEvoy et al., 2015); however, a study of
older adults (mean age = 83, SD = 2.8; n= 311) suggests that much
longer duration of high and variable SBP was associated with worse
white matter integrity (Rosano et al., 2015). These ﬁndings support a
need for further study of more recent onset hypertensive individualsTable 5
Trivariate twin model ﬁtting results for AWM, SBP, and DBP.
Standardized variance components
a2 c2 e2
SBPa,b 0.44 (0.20; 0.54) 0.01 (0.00; 0.21) 0.54 (0.46;
DBPa,b 0.46 (0.24; 0.55) 0.01 (0.00; 0.19) 0.52 (0.45;
Proportion of AWMc 0.80 (0.56; 0.86) 0.01 (0.00; 0.23) 0.19 (0.14;
a2 = Additive genetic, c2 = Common/Shared environmental, and e2 = Unique environmenta
conﬁdence intervals in parentheses. a BP estimates weremedication corrected (Rana et al., 2014
and age.and longitudinal follow-up of VETSA participants to assess if longer du-
ration is, in fact, associated with more AWM.
There was no effect of carrying the ε4 allele on AWM in this midlife
sample. Another studywith a broad age range also found no association
(Hirono et al., 2000), although ε4 has been associated with more white
matter disease in older individuals and Alzheimer's disease (Brickman
et al., 2014). However, it remains possible that such effects are regional-
ly speciﬁc, as suggested by a ratings-based study demonstrating more
AWM only in subcortical regions for hypertensive ε4 carriers (de
Leeuw et al., 2004), and by our diffusion study that reported an interac-
tion between hypertension and ε4 status within the uncinate and infe-
rior fronto-occipital fasciculi only (McEvoy et al., 2015).
The genetic inﬂuence on AWM is high. Heritabilitywas similar in our
middle-aged cohort (0.81) relative to the older NHLBI (Carmelli et al.,
1998) (0.71) and OATS (Sachdev et al., 2013) (0.79) cohorts, and higher
than the Framingham non-twin pedigree-based study across a wider
age range (0.55) (Atwood et al., 2004). Although methodology is rele-
vant in comparing across studies, as the imaging sequences used in seg-
mentation varied, comparison to other studies may suggest an increase
in the inﬂuence of genetic factors with increasing age. However, while
AWM shared some genetic inﬂuences with SBP, no genetic correlation
was evident for DBP, and there was evidence for the contribution of
unique environmental and genetic inﬂuences independent from those
associated with hypertension and blood pressure. Common environ-
mental inﬂuences (c2) did not signiﬁcantly contribute. Although exactly
when common (shared) environment is most likely to inﬂuence the
brain is not yet known, in most adult studies, there often is little to no
indication of “C” effects with respect to MRI phenotypes (Blokland et
al., 2012). Prior work in other research areas suggests that the inﬂuence
of a common environment may diminish later in life when individuals
have been living apart longer (Silventoinen et al., 2010; Sundet et al.,
2008). Our sample of men in late middle age is relatively far removed
from any common environmental inﬂuences, and they are at an age
when measures of brain pathology may be more inﬂuenced by genetic
and unique environmental factors.
Although the current study is limited in generalization,with a cohort
that is solely male and largely Caucasian, the study's restriction to men
in a narrow age range reduces variability that may be associated with
age and gender in both prevalence and heritability of hypertension
and age-associated white matter disease (Atwood et al., 2004; de
Leeuw et al., 2001). Subgroup comparisons for duration of hypertension
may be limited in power due to small sample sizes, requiring replication
and follow-up.Correlation with proportion of AWM
rP rA rE
0.63) 0.18 (0.07; 0.28) 0.26 (0.02; 0.71) 0.11 (−0.09; 0.31)
0.61) 0.12 (0.01; 0.22) 0.14 (−0.08; 0.52) 0.14 (−0.05; 0.31)
0.27) – – –
l inﬂuences. rP = phenotypic, rA = genetic, rE = unique environmental correlations. 95%
). b BP estimation includes non-MRI participants (Rana et al., 2014). c Adjusted for scanner
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In this midlife cohort in the midst of emerging hypertension, signif-
icant white matter abnormalities were evident, predominantly in
periventricular regions and in deep parietal and frontal white matter.
These abnormalities were associated with hypertension, particularly
in individuals with uncontrolled hypertension. This suggests that
AWMmay reﬂect currently active cerebrovascular effects; future work
will explore comparisons with microstructural measures of white mat-
ter disease (i.e., diffusion MRI) which may provide evidence for more
permanent or longer-lasting white matter damage. Furthermore,
while AWM was highly heritable and shared some genetic inﬂuences
with SBP, no genetic correlation was evident for DBP. There was evi-
dence for the contribution of unique environmental and genetic inﬂu-
ences independent from those associated with BP. Given the
importance of early identiﬁcation and treatment of cardiovascular-re-
lated risk factors, research focused on individual differences and factors
impacting white matter disease speciﬁcally in midlife is of importance.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.10.001.
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